跳至主要内容
临床试验/CTRI/2020/12/029476
CTRI/2020/12/029476尚未招募2 期

Effect of purified standard extract of Withania somnifera, Phyllanthus emblica and Shilajeet in SARS-CoV-2 recovery patients

ATREON INC0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age 18-60 years
  • Presently SARS-CoV-2 RT-PCR test negative
  • Who have recovered from SARS-CoV-2
  • Mild to moderate SARS-CoV-2 infection in the past
  • Having a hospital discharge report of SARS-CoV-2
  • Residence within the catchment area of the hospital
  • Provision of signed informed consent

排除标准

  • Age below 18 years and above 60 years
  • Signs& symptoms of SARS COV-2
  • Past history of serious cardiac problem
  • Past history of severe diabetes
  • Past history of serious renal failure
  • Past history of serious respiratory diseases
  • Past history of serious liver disorders
  • Past history of serious mental disorders
  • Presently pregnant or lactating women or expecting to become pregnant during the study period
  • Unwilling to give written consent
  • Use of any medications or supplements which, in the opinion of the investigators, may influence the results of the study

研究者

发起方
ATREON INC

相似试验